central pharmacies (uk) limited

5

central pharmacies (uk) limited Company Information

Share CENTRAL PHARMACIES (UK) LIMITED
Live 
MatureMidHealthy

Company Number

SC230534

Website

-

Registered Address

suite 4, pavilion 3, st james business park, paisley, PA3 3BB

Industry

Dispensing chemist in specialised stores

 

Telephone

01412216201

Next Accounts Due

December 2024

Group Structure

View All

Directors

Gavin McLaren22 Years

Parvez Aslam22 Years

Shareholders

qpp holdings limited 100%

central pharmacies (uk) limited Estimated Valuation

£1.8m

Pomanda estimates the enterprise value of CENTRAL PHARMACIES (UK) LIMITED at £1.8m based on a Turnover of £6.2m and 0.29x industry multiple (adjusted for size and gross margin).

central pharmacies (uk) limited Estimated Valuation

£4.7m

Pomanda estimates the enterprise value of CENTRAL PHARMACIES (UK) LIMITED at £4.7m based on an EBITDA of £1.2m and a 3.97x industry multiple (adjusted for size and gross margin).

central pharmacies (uk) limited Estimated Valuation

£8.9m

Pomanda estimates the enterprise value of CENTRAL PHARMACIES (UK) LIMITED at £8.9m based on Net Assets of £3.9m and 2.27x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Central Pharmacies (uk) Limited Overview

Central Pharmacies (uk) Limited is a live company located in paisley, PA3 3BB with a Companies House number of SC230534. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in April 2002, it's largest shareholder is qpp holdings limited with a 100% stake. Central Pharmacies (uk) Limited is a mature, mid sized company, Pomanda has estimated its turnover at £6.2m with healthy growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Central Pharmacies (uk) Limited Health Check

Pomanda's financial health check has awarded Central Pharmacies (Uk) Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

5 Strong

positive_score

3 Regular

positive_score

4 Weak

size

Size

annual sales of £6.2m, make it smaller than the average company (£12.1m)

£6.2m - Central Pharmacies (uk) Limited

£12.1m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 14%, show it is growing at a faster rate (5.4%)

14% - Central Pharmacies (uk) Limited

5.4% - Industry AVG

production

Production

with a gross margin of 31.9%, this company has a comparable cost of product (31.9%)

31.9% - Central Pharmacies (uk) Limited

31.9% - Industry AVG

profitability

Profitability

an operating margin of 18.3% make it more profitable than the average company (3.4%)

18.3% - Central Pharmacies (uk) Limited

3.4% - Industry AVG

employees

Employees

with 53 employees, this is below the industry average (84)

53 - Central Pharmacies (uk) Limited

84 - Industry AVG

paystructure

Pay Structure

on an average salary of £22k, the company has an equivalent pay structure (£22k)

£22k - Central Pharmacies (uk) Limited

£22k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £116.7k, this is less efficient (£139.2k)

£116.7k - Central Pharmacies (uk) Limited

£139.2k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 44 days, this is later than average (31 days)

44 days - Central Pharmacies (uk) Limited

31 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 79 days, this is slower than average (69 days)

79 days - Central Pharmacies (uk) Limited

69 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 29 days, this is in line with average (30 days)

29 days - Central Pharmacies (uk) Limited

30 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 75 weeks, this is more cash available to meet short term requirements (15 weeks)

75 weeks - Central Pharmacies (uk) Limited

15 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 32.4%, this is a lower level of debt than the average (61.7%)

32.4% - Central Pharmacies (uk) Limited

61.7% - Industry AVG

CENTRAL PHARMACIES (UK) LIMITED financials

EXPORTms excel logo

Central Pharmacies (Uk) Limited's latest turnover from March 2023 is estimated at £6.2 million and the company has net assets of £3.9 million. According to their latest financial statements, Central Pharmacies (Uk) Limited has 53 employees and maintains cash reserves of £2.2 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Turnover6,184,2115,376,4124,138,7034,223,8783,855,2174,025,2213,532,6993,899,2035,556,6386,000,2374,194,0293,344,6695,139,3674,711,880
Other Income Or Grants00000000000000
Cost Of Sales4,210,9923,647,4232,875,2462,991,0292,729,6012,795,6752,425,9232,698,3473,880,5204,156,3642,919,5412,368,2563,615,3183,280,634
Gross Profit1,973,2191,728,9891,263,4571,232,8501,125,6171,229,5461,106,7761,200,8561,676,1181,843,8731,274,488976,4131,524,0481,431,246
Admin Expenses841,4131,868,450219,632655,386534,560667,520418,7941,191,9881,729,7532,139,0201,481,340-201,9731,661,7811,598,014
Operating Profit1,131,806-139,4611,043,825577,464591,057562,026687,9828,868-53,635-295,147-206,8521,178,386-137,733-166,768
Interest Payable57,04821,0501,5887,62819,49022,00322,32913,5510005,24914,8099,560
Interest Receivable86,16115,9992,2222,01213,9128,2052,9503,3932,3643,5495,5664,1112,3091,265
Pre-Tax Profit1,160,919-144,5121,044,459571,848585,479548,228668,604-1,290-51,271-291,598-201,2861,177,247-150,233-175,062
Tax-220,5750-198,447-108,651-111,241-104,163-133,7210000-306,08400
Profit After Tax940,344-144,512846,012463,197474,238444,065534,883-1,290-51,271-291,598-201,286871,163-150,233-175,062
Dividends Paid00000000000000
Retained Profit940,344-144,512846,012463,197474,238444,065534,883-1,290-51,271-291,598-201,286871,163-150,233-175,062
Employee Costs1,163,7041,089,477949,509927,466906,317894,310814,467782,691828,645878,658574,569437,454659,806570,094
Number Of Employees5353494949494645485134263934
EBITDA*1,173,107-90,5971,082,291614,404651,973714,329841,432529,430350,01185,708135,4801,523,617312,673288,454

* Earnings Before Interest, Tax, Depreciation and Amortisation

Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Tangible Assets478,941501,318464,290447,467350,205119,514123,569143,544168,004172,06793,265104,855251,850271,113
Intangible Assets0000044,307177,241310,174805,2441,187,7241,020,7591,350,0692,138,7002,568,009
Investments & Other10010010010010010000000000
Debtors (Due After 1 year)00000000000000
Total Fixed Assets479,041501,418464,390447,567350,305163,921300,810453,718973,2481,359,7911,114,0241,454,9242,390,5502,839,122
Stock & work in progress339,541358,921351,878414,869315,721343,280336,735316,367352,673326,864290,775298,084390,306357,911
Trade Debtors758,026559,688412,586445,447404,272455,314371,462479,299782,689871,152682,866491,115703,582653,411
Group Debtors00000000000000
Misc Debtors2,044,8431,780,2092,561,893426,730322,737359,109430,264423,89755,9294,8215,0353,63500
Cash2,164,6041,890,0172,376,4132,068,3481,956,5551,753,2361,528,928831,409525,758419,773999,7581,226,748417,544506,155
misc current assets00000000000000
total current assets5,307,0144,588,8355,702,7703,355,3942,999,2852,910,9392,667,3892,050,9721,717,0491,622,6101,978,4342,019,5821,511,4321,517,477
total assets5,786,0555,090,2536,167,1603,802,9613,349,5903,074,8602,968,1992,504,6902,690,2972,982,4013,092,4583,474,5063,901,9824,356,599
Bank overdraft135,772132,104052,064144,400178,916120,664117,232000000
Bank loan00000000000000
Trade Creditors 914,127870,902829,5151,011,507837,074908,716792,718744,1131,020,3531,467,8771,003,903937,6301,306,0511,239,269
Group/Directors Accounts000243,8110000000000
other short term finances00000000000000
hp & lease commitments00000000000000
other current liabilities432,623587,8052,187,796194,505495,373441,049976,09197,859000000
total current liabilities1,482,5221,590,8113,017,3111,501,8871,476,8471,528,6811,889,473959,2041,020,3531,467,8771,003,903937,6301,306,0511,239,269
loans353,662491,6010053,636200,522176,908299,7290000161,515294,145
hp & lease commitments00000000000000
Accruals and Deferred Income00000000000000
other liabilities00000000418,396218,089507,101752,8171,520,5461,756,252
provisions36,22134,53532,03129,26810,49811,28611,51214,33418,83512,4515,8727,1918,16510,995
total long term liabilities389,883526,13632,03129,26864,134211,808188,420314,063437,231230,540512,973760,0081,690,2262,061,392
total liabilities1,872,4052,116,9473,049,3421,531,1551,540,9811,740,4892,077,8931,273,2671,457,5841,698,4171,516,8761,697,6382,996,2773,300,661
net assets3,913,6502,973,3063,117,8182,271,8061,808,6091,334,371890,3061,231,4231,232,7131,283,9841,575,5821,776,868905,7051,055,938
total shareholders funds3,913,6502,973,3063,117,8182,271,8061,808,6091,334,371890,3061,231,4231,232,7131,283,9841,575,5821,776,868905,7051,055,938
Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010
Operating Activities
Operating Profit1,131,806-139,4611,043,825577,464591,057562,026687,9828,868-53,635-295,147-206,8521,178,386-137,733-166,768
Depreciation41,30148,86438,46636,94016,60919,36920,51725,49221,16616,09813,02215,92121,09725,913
Amortisation000044,307132,934132,933495,070382,480364,757329,310329,310429,309429,309
Tax-220,5750-198,447-108,651-111,241-104,163-133,7210000-306,08400
Stock-19,3807,043-62,99199,148-27,5596,54520,368-36,30625,80936,089-7,309-92,22232,395357,911
Debtors462,972-634,5822,102,302145,168-87,41412,697-101,47064,578-37,355188,072193,151-208,83250,171653,411
Creditors43,22541,387-181,992174,433-71,642115,99848,605-276,240-447,524463,97466,273-368,42166,7821,239,269
Accruals and Deferred Income-155,182-1,599,9911,993,291-300,86854,324-535,042878,23297,859000000
Deferred Taxes & Provisions1,6862,5042,76318,770-788-226-2,822-4,5016,3846,579-1,319-974-2,83010,995
Cash flow from operations398,669-1,019,158658,595153,772637,599171,6541,712,828318,276-79,583332,10014,5921,149,192294,059527,396
Investing Activities
capital expenditure-18,924-85,892-55,289-134,202-247,300-15,314-542-1,032-17,103-626,622-1,432590,395-1,834-3,294,344
Change in Investments0000010000000000
cash flow from investments-18,924-85,892-55,289-134,202-247,300-15,414-542-1,032-17,103-626,622-1,432590,395-1,834-3,294,344
Financing Activities
Bank loans00000000000000
Group/Directors Accounts00-243,811243,8110000000000
Other Short Term Loans 00000000000000
Long term loans-137,939491,6010-53,636-146,88623,614-122,821299,729000-161,515-132,630294,145
Hire Purchase and Lease Commitments00000000000000
other long term liabilities0000000-418,396200,307-289,012-245,716-767,729-235,7061,756,252
share issue000000-876,0000000001,231,000
interest29,113-5,051634-5,616-5,578-13,798-19,379-10,1582,3643,5495,566-1,138-12,500-8,295
cash flow from financing-108,826486,550-243,177184,559-152,4649,816-1,018,200-128,825202,671-285,463-240,150-930,382-380,8363,273,102
cash and cash equivalents
cash274,587-486,396308,065111,793203,319224,308697,519305,651105,985-579,985-226,990809,204-88,611506,155
overdraft3,668132,104-52,064-92,336-34,51658,2523,432117,232000000
change in cash270,919-618,500360,129204,129237,835166,056694,087188,419105,985-579,985-226,990809,204-88,611506,155

central pharmacies (uk) limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for central pharmacies (uk) limited. Get real-time insights into central pharmacies (uk) limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Central Pharmacies (uk) Limited Competitor Analysis

BETA
competitor_analysis_table_img

Perform a competitor analysis for central pharmacies (uk) limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

central pharmacies (uk) limited Ownership

CENTRAL PHARMACIES (UK) LIMITED group structure

Central Pharmacies (Uk) Limited has 1 subsidiary company.

Ultimate parent company

1 parent

CENTRAL PHARMACIES (UK) LIMITED

SC230534

1 subsidiary

CENTRAL PHARMACIES (UK) LIMITED Shareholders

qpp holdings limited 100%

central pharmacies (uk) limited directors

Central Pharmacies (Uk) Limited currently has 2 directors. The longest serving directors include Mr Gavin McLaren (Apr 2002) and Mr Parvez Aslam (Apr 2002).

officercountryagestartendrole
Mr Gavin McLarenScotland52 years Apr 2002- Director
Mr Parvez AslamScotland63 years Apr 2002- Director

P&L

March 2023

turnover

6.2m

+15%

operating profit

1.1m

0%

gross margin

32%

-0.78%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

March 2023

net assets

3.9m

+0.32%

total assets

5.8m

+0.14%

cash

2.2m

+0.15%

net assets

Total assets minus all liabilities

central pharmacies (uk) limited company details

company number

SC230534

Type

Private limited with Share Capital

industry

47730 - Dispensing chemist in specialised stores

incorporation date

April 2002

age

22

accounts

Total Exemption Full

ultimate parent company

previous names

N/A

incorporated

UK

address

suite 4, pavilion 3, st james business park, paisley, PA3 3BB

last accounts submitted

March 2023

central pharmacies (uk) limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 1 charges/mortgages relating to central pharmacies (uk) limited. Currently there are 1 open charges and 0 have been satisfied in the past.

charges

central pharmacies (uk) limited Companies House Filings - See Documents

datedescriptionview/download